Rankings
▼
Calendar
ELAN Q4 2023 Earnings — Elanco Animal Health Incorporated Revenue & Financial Results | Market Cap Arena
ELAN
Elanco Animal Health Incorporated
$12B
Q4 2023 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$1.0B
+4.8% YoY
Gross Profit
$381M
36.8% margin
Operating Income
$10M
1.0% margin
Net Income
-$141M
-13.6% margin
EPS (Diluted)
$-0.29
QoQ Revenue Growth
-3.1%
Cash Flow
Operating Cash Flow
$157M
Free Cash Flow
$116M
Stock-Based Comp.
$15M
Balance Sheet
Total Assets
$14.4B
Total Liabilities
$8.1B
Stockholders' Equity
$6.2B
Cash & Equivalents
$352M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.0B
$988M
+4.8%
Gross Profit
$381M
$410M
-7.1%
Operating Income
$10M
$27M
-63.0%
Net Income
-$141M
-$54M
-161.1%
Revenue Segments
Farm Animal
$610M
38%
Pet Health
$416M
26%
Cattle
$249M
16%
Poultry
$220M
14%
Swine
$98M
6%
Contract Manufacturing
$9M
1%
Geographic Segments
Non-US
$574M
55%
UNITED STATES
$461M
45%
← FY 2023
All Quarters
Q1 2024 →